Bristol-Meyers Squibb (BMY) - Goldman Saches says BUY

Goldman Sachs says to buy Bristol-Myers Squibb Company (NYSE: BMY) ahead of the release of ipi PDUFA. Goldman has a $30 price target on shares

Read more: http://www.benzinga.com/analyst-ratings/analyst-color/11/03/952216/goldman-sachs-says-buy-bristol-myers-squibb-company-bmy#ixzz1HcUAtOPq

BMY was first mentioned in my previous blog post.